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Beat-to-beat variability of cardiac action potential duration:
underlying mechanism and clinical implications1
Péter P. Nánási, János Magyar, András Varró, and Balázs Ördög
Abstract: Beat-to-beat variability of cardiac action potential duration (short-term variability, SV) is a common feature of various
cardiac preparations, including the human heart. Although it is believed to be one of the best arrhythmia predictors, the
underlying mechanisms are not fully understood at present. The magnitude of SV is basically determined by the intensity of
cell-to-cell coupling in multicellular preparations and by the duration of the action potential (APD). To compensate for the
APD-dependent nature of SV, the concept of relative SV (RSV) has been introduced by normalizing the changes of SV to the
concomitant changes in APD. RSV is reduced by ICa, IKr, and IKs while increased by INa, suggesting that ion currents involved in
the negative feedback regulation of APD tend to keep RSV at a low level. RSV is also inﬂuenced by intracellular calcium
concentration and tissue redox potential. The clinical implications of APD variability is discussed in detail.
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Résumé : La variabilité battement par battement de la durée du potentiel d’action cardiaque (variabilité a` court terme, VC) est
une caractéristique commune de diverses préparations cardiaques, y compris de cœur humain. Bien que l’on croie que ce soit le
meilleur facteur prédictif de l’arythmie, on n’en comprend pas a` l’heure actuelle les modes d’action intimes. L’amplitude de la
VC est déterminée fondamentalement par l’intensité du couplage intercellulaire dans des préparations pluricellulaires et par la
durée du potentiel d’action (DPA). Aﬁn de compenser le fait que la VC soit dépendante de la DPA, nous avons introduit le concept
de VC relative (VCR) en normalisant les variations de la VC sur la base des variations concomitantes de la DPA. Nous avons observé
qu’ICa, IKr et IKs entraînent une diminution de la VCR tandis qu’INa a l’effet inverse, ce qui laisse entendre que les courants
ioniques jouant un rôle dans la régulation de la rétroaction négative de la DPA tendraient a`maintenir la VCR a` des valeurs basses.
La VCR est aussi inﬂuencée par les concentrations intracellulaires de calcium et le potentiel redox des tissus. Les répercussions
cliniques de la variabilité de la DPA sont discutées en détail. [Traduit par la Rédaction]
Mots-clés : durée du potentiel d’action, arythmie, canaux ioniques, variabilité battement par battement.
Introduction
Action potential duration (APD) is generally uniform under
given experimental conditions; however, there is a small scatter-
ing in APD when consecutive action potentials are analyzed. This
is deﬁned as beat-to-beat variability or short-term variability (SV)
of APD, which has been observed in a variety of mammalian car-
diac preparations, including human (Hinterseer et al. 2008, 2009,
2010; Sur et al. 2013; Tereshchenko et al. 2010), canine (Abi-Gerges
et al. 2010; Thomsen et al. 2004, 2006; Schneider et al. 2005;
van der Linde et al. 2005), rabbit (Jacobson et al. 2011; Michael et al.
2007), and guinea pig (Zaniboni et al. 2000) hearts. SV is usually
formulated by the following equation:
SV  (|APDn1  APDn|)/(nbeats × 2)
where SV is the short-term variability, APDn and APDn+1 indicate
the durations of the nth and (n+1)th action potentials, respectively,
at 90% level of repolarization, and nbeats denotes the number of
consecutive beats (typically 20–50) analyzed (Johnson et al. 2010;
Szentandrássy et al. 2015).
Hinterseer and coworkers emphasized the predictive value of
the increased variability regarding arrhythmia incidence in pa-
tients with cardiomyopathy or heart failure and in individuals
having ion channel mutations leading to cardiac arrhythmias
(Hinterseer et al. 2008, 2009, 2010). These results have been cor-
roborated later using in vivo and in vitro animal models of drug-
induced torsades de pointes type arrhythmias by applying D-sotalol,
dofetilide, or setindole to suppress the rapidly activating delayed
rectiﬁer K+ current (Abi-Gerges et al. 2010; Thomsen et al. 2004,
2006; van der Linde et al. 2005). Now, it is generally accepted that
SV is a good predictor of the torsade-related arrhythmia incidence
(Abi-Gerges et al. 2010; Jacobson et al. 2011; Tereshchenko et al.
2010; Thomsen et al. 2004; van der Linde et al. 2005), even better
than triangulation or QT prolongation itself (Abi-Gerges et al.
2010; Hinterseer et al. 2008, 2009, 2010; Thomsen et al. 2006). This
is because the elevation of SV results automatically in an in-
creased temporal inhomogeneity, which is considered as a sub-
strate for reentrant arrhythmias.
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In spite of the potential clinical importance of SV, its ionic
mechanism remained hidden for a long period of time. Although
it was evident that stochastic gating of cardiac ion channels is the
basic underlying mechanism of SV (Lemay et al. 2011; Pueyo et al.
2011), contribution of the individual ion currents have been eluci-
dated only in the recent years. In the present paper, we review all
aspects of SV inmulticellular and single cell cardiac preparations,
including its ionic mechanism and the factors inﬂuencing SV.
SV in multicellular cardiac tissues: role of cell-to-cell
coupling
When comparing the variability in healthy multicellular and
single cellmammalian preparations, it turned out that SV ismuch
smaller in multicellular cardiac tissues than in single cells (Magyar
et al. 2015). This is due to the balancing effect of the neighboring
myocytes through the open gap junctions. Zaniboni et al. have
elegantly shown, using cell pairs coupled electrically through a
100 M resistance, that SV was decreased in both myocytes after
electrical coupling (Zaniboni et al. 2000). In line with this, rotiga-
peptide, a gap junction opener peptide, was shown to suppress
arrhythmogenic discordant alternans in ischemic guinea pig
hearts. This indicates that intact cell-to-cell coupling is an impor-
tant factor to keep APD variability at a low level in vivo (Kjølbye
et al. 2008). Because SV is very low in multicellular preparations
and, more importantly, because its magnitude is mostly inﬂu-
enced by the degree of cell-to-cell coupling, multicellular prepa-
rations are not really suitable for studying the speciﬁc ionic
mechanisms involved in governing SV.
SV in single cardiomyocytes: role of APD and the
concept of relative SV
Ion substitution and the application of selective blockers and
activators of ion channels are the simplest strategies to identify
the role of individual ion currents in SV. Following the latter
approach, it became evident that APD itself has a strong inﬂuence
of SV: SV was sharply increasing with lengthening of action po-
tentials (Heijman et al. 2013; Johnson et al. 2010; Szentandrássy
et al. 2015). Indeed, SVwas shown to be an exponential function of
APD, when APs were lengthened and shortened using inward and
outward current pulses, respectively, injected throughout the en-
tire plateau (Szentandrássy et al. 2015; Fig. 1). APD elongation and
shortening, induced by current injections, can be basically con-
sidered as an “ion-channel-independent” manipulation of APD.
Therefore, the exponential curve in Fig. 1B can be used as a refer-
ence allowing to visualize the pure consequences of APD changes,
which are generally apparent in response to drug actions target-
ing cardiac ion channels. To eliminate the APD-related changes
of SV, the term relative SV (RSV) has been introduced by plotting
SV as a function of APD (Fig. 1B). Similar results were obtained
when the changes in SV were plotted against the concomitant
changes in APD (Fig. 1C). Accordingly, data points located above
the curves correspond to increased RSV, while those located un-
der the curves indicate reduction of RSV. Thus, RSV is suitable for
studying the speciﬁc effect of a drug or intervention on beat-to-
beat variability of APD.
Ionic mechanism of variability: contribution of
individual ion currents
The contribution of individual ion currents to SV was revealed
by using selective blockers and activators of ion channels. Sup-
pression of IKr by dofetilide increased SV in single canine ventric-
ular cells (Johnson et al. 2010) and in vivo rabbit hearts, but failed
to modify SV in conscious dogs (Lengyel et al. 2007). In Langendorff-
perfused rabbit hearts, IKr was also suppressed by low concentrations
of quinidine and amiodarone: SV was increased by quinidine (Wu
et al. 2008a), but not by amiodarone (Wu et al. 2008b). Similarly,
selective inhibition of IKs by HMR-1556 increased SV in isolated
canine myocytes (Johnson et al. 2010), but had no effect on SV
under in vivo conditions in dogs and rabbits (Lengyel et al. 2007).
However, when applying simultaneous blockade of IKr and IKs
(using HMR-1556 plus dofetilide), SV was largely elevated in both
species (Lengyel et al. 2007). The role of Na+ current was studied
using ATX-II to enhance and tetrodotoxin (TTX) to suppress INa.
ATX-II increased SV in isolated canine ventricular cells (Johnson
et al. 2010) as well as in Langendorff-perfused rabbit hearts (Wu
et al. 2008a, 2008b). SV was reduced by TTX in guinea pig ventric-
ular cells (Zaniboni et al. 2000), similarly to high concentrations of
quinidine and amiodarone (applied to block INa) in Langendorff-
perfused rabbit hearts (Wu et al. 2008a, 2008b). SV was decreased
by isoproterenol when canine myocytes were superfused with
isoproterenol in the presence of dofetilide or ATX-II, but increased
when isoproterenol was applied following pretreatment with
HMR-1556 (Gallacher et al. 2007; Johnson et al. 2010). These results
suggest that SV was strongly reduced by IKr and increased by INa,
while IKs had probably a weak suppressive effect. However, inter-
pretation of these results is somewhat difﬁcult because the drug
actions on SV were not correlated with the concomitant changes
of APD. This was performed by Szentandrássy et al., who took APD
changes into account and reported the effects of several selective
ion channel activators and inhibitors on RSV in canine ventricular
myocytes (Szentandrássy et al. 2015; Fig. 2). According to Fig. 1,
data points located above and under the curves correspond to
increased and decreased RSV, respectively. RSV was increased by
dofetilide, HMR-1556, the INa activator veratridine, and the ICa
blocker nisoldipine. On the other hand, RSV was reduced by TTX
and the ICa activator BAY K8644, while remained unaffected by
the ATP-sensitive K+ channel opener lemakalim. This was direct
evidence indicating that RSV was reduced by ICa, IKr, and IKs, in-
Fig. 1. Concept of relative variability as showing the effect of action
potential duration (APD) on short- term variability (SV). Data were
obtained in canine myocytes using outward and inward current pulses
to shorten and lengthen action potentials, respectively (Szentandrássy
et al. 2015). (A) Selected superimposed sets of 50 consecutive action
potentials to demonstrate changes in action potential morphology
induced by the injected current. The exponential curve in panel (B) was
obtained by plotting SV data as a function of the corresponding APD
values. (C) Similar treatment of data, but here SV changes evoked by
the current pulses were plotted against the respective APD changes.
Any theoretical point located above these curves represents data with
increased relative SV (RSV), while those being below the curves indicate
reduced RSV values. This approach allows the evaluation of drug effects
on variability independently of their actions on the magnitude of APD.
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creased by INa, and not inﬂuenced by background K+ conduc-
tances, like IK-ATP or IK1 (Szentandrássy et al. 2015).
Without questioning the role of the stochastic nature of chan-
nel gating in beat-to-beat variability (Lemay et al. 2011; Pueyo et al.
2011), the above results provided an essentially new interpretation
of the phenomenon. This interpretation suggests that the well-
known negative feedback regulation of APD (based on the ﬁnely
tuned and voltage-coupled interplay between the amplitude of ICa
and the activation of repolarizing K+ currents) may be an impor-
tant factor in the modulation of SV. In line with this theory, INa is
not expected to decrease SV, because the late Na+ current is acti-
vated predominantly during the terminal phase of the plateau
(Horváth et al. 2013; Liu et al. 1992; Zaza and Rocchetti 2013),
where there is no room for further activation of IKr or IKs. In
contrast to INa-late, ICa has the highest amplitude at the beginning
of the plateau phase having stronger inﬂuence on the subsequent
activation of IKr and IKs (Bányász et al. 2003). In addition, because
the membrane resistance is extraordinarily high during the late
plateau (Zaniboni et al. 2000), a relatively small inward shift in the
net membrane current may result in a large instability of APD
(Bányász et al. 2009; Bárándi et al. 2010). This also gives the phys-
ical basis of the logarithmic relationship between SV and APD, as
was predicted by the simulations of Heijman et al. (2013) and
conﬁrmed experimentally by Szentandrássy et al. (2015). As shown
in Fig. 2, RSV was decreased by a low concentration of isoproter-
enol giving a strong support to this interpretation, because iso-
proterenol is known to increase massively both ICa and IKs, and to
a smaller extent IKr, in canine ventricular myocardium (Harmati
et al. 2011).
IKr, IKs, and ICa, therefore, appear to reduce SV. Blocking these
currents directly using class 3 and class 4 antiarrhythmics, or
indirectly by class 2 drugs (beta receptor blockers), on the other
hand, results in increased SV. An important clinical implication
of these ﬁndings is that the antiarrhythmic potency of ion chan-
nel blockers acting on IKr, IKs, and ICa may be limited by the con-
comitant effect of these drugs to increase beat-to-beat variability
of APD.
Factors influencing RSV
Ischemia–reperfusion injury, a massive source of life-threatening
cardiac arrhythmias, is also associated with increased beat-to-beat
variability of APD (Kormos et al. 2014; Sarusi et al. 2014). Reperfu-
sion of the ischemic tissue leads to increased Ca2+ load, acidosis,
and oxidative shift in the tissue redox potential. Elevation of
[Ca2+]i and decrease of intracellular pH results in disconnection of
gap junctions (Dekker et al. 1996; Maurer and Weingart 1987;
White et al. 1990) causing conduction block (De Groot and Coronel
2004; Kléber 1992). In addition, reduced electrical coupling also
increases SV in multicellular preparations (Kjølbye et al. 2008;
Zaniboni et al. 2000). Beyond these effects, evident in multicellu-
lar cardiac tissues, recent results indicated that RSVwas increased
by elevation of [Ca2+]i in single cardiomyocytes as well. Reduction
of [Ca2+]i by chelating intracellular Ca2+ using BAPTA-loaded cells
(BAPTA-AM) decreased, while increasing intracellular Ca2+ using
the Ca2+ ionophore A23187 increased RSV (Kistamás et al. 2015a).
This effect of intracellular BAPTA was more pronounced when
early afterdepolarizations were evoked by dofetilide pretreat-
ment (Horváth et al. 2015). It was revealed that Ca2+ released from
the sarcoplasmic reticulum plays a critical role, because RSV was
equally decreased by ryanodine and cyclopiazonic acid (Kistamás
et al. 2015a). The former inhibits the ryanodine receptor (Meissner
1986), whereas the latter blocks the reﬁlling of the sarcoplasmic
reticulum (Takahashi et al. 1995; Yard et al. 1994). However, both
agents result in a smaller Ca2+ release from the sarcoplasmic re-
ticulum. Spontaneous diastolic Ca2+ release, evoked by high con-
centrations of isoproterenol (100 nmol/L), was also shown to
increase SV and APD (Johnson et al. 2013). Low concentrations of
isoproterenol (10 nmol/L), on the other hand, reduced both para-
meters in the same species (SV to a larger extent than APD, so RSV
was markedly decreased by 10 nmol/L isoproterenol) (Szentandrássy
et al. 2015). The concentration-dependent differences observed in
the isoproterenol effects are likely consequences of the combina-
tion of 2 actions of isoproterenol: the enhancement of ICa, IKs, and
IKr and the elevation of [Ca2+]i. A relatively low concentration of
isoproterenol is sufﬁcient to activate the transmembrane ion cur-
rents (the respective EC50 values are 15.3, 14.5, and 13.7 nmol/L for
ICa, IKs, and IKr) (Szentandrássy et al. 2012), while higher isoproter-
enol concentrations are required to overload the cells with Ca2+.
As it has been discussed previously, RSV is reduced by the former
but increased by the latter effect of isoproterenol.
The role of the sodium–calcium exchanger (NCX) in beat-to-beat
variability has been also studied (Kistamás et al. 2015a). A moder-
ate concentration (300 nmol/L) of SEA0400, a relatively selective
inhibitor of NCX, increased SV, while APD was concomitantly
shortened, indicating an elevation of RSV by SEA0400. It is not
clear, however, that this effect was a direct consequence of sup-
pression of the NCX current (in this case, NCX itself should be
considered as a reducer of RSV) or, alternatively, the changes in RSV
were associated with the consecutive changes in Ca2+ handling.
The mechanism of the [Ca2+]i-dependent modulation of RSV is
not fully understood, although alterations in Ca2+-dependent ion
currents (e.g., augmentation of the Ca2+-dependent inactivation of
ICa resulting in a reduction of ICa amplitude) are likely to be in-
volved. It must be borne in mind, however, that the proarrhyth-
mic potency of Ca2+ overload is accentuated in multicellular
preparations by the concomitant disconnection of gap junctions.
Gross changes in redox potential occur in cardiac tissues during
ischemia–reperfusion injury, characteristically accompanied by
an increased incidence of arrhythmias (Becker and Ambrosio
1987). In a recent study, the effect of redox potential changes on
beat-to-beat variability has been demonstrated (Kistamás et al.
2015b). RSV was decreased by applying a reductive environment
(containing DL-dithiothreitol, reduced L-glutathione, and L-ascorbic
acid). However, shifting the redox potential in the oxidative direc-
tion by H2O2 strongly increased RSV and resulted in development
of early afterdepolarizations. These effects of H2O2 could be pre-
vented by pretreatment with reducing agents, indicating that the
elevation of RSVwas really caused by the oxidative shift (Kistamás
et al. 2015b). Because similar changes are known to occur under
conditions of oxidative stress, it is plausible to assume that the
increased RSV due to oxidative shiftsmay contribute to the higher
arrhythmia incidence observed under these pathological condi-
Fig. 2. Effects of selective ion channel activators and inhibitors on
relative short-term variability (SV) to demonstrate the contribution of
the corresponding current to beat-to-beat variability (Szentandrássy
et al. 2015). Panels (A) and (B) show plots of SV versus action potential
duration (APD) and drug-induced changes of SV versus drug-induced
APD changes, respectively. CTRL, pooled control; DOF, 300 nmol/L
dofetilide; VER, 100 nmol/L veratridine; HMR, 500 nmol/L HMR 1556;
NISO, 1mol/L nisoldipine; LEM, 300 nmol/L lemakalim; BAYK, 20 nmol/L
BAY K8644; TTX, 3mol/L tetrodotoxin; and ISO, 10 nmol/L isoproterenol.
The exponential curves are identical to those shown in Fig. 1.
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tions. Regarding the possible underlying mechanism, it was spec-
ulated that the increased late Na+ current combined with the
elevated [Ca2+]i may probably be responsible for the elevation of
RSV. Both changes are known to be consequences of an oxidative
shift in the redox potential. The amplitude of Na+ current was
increased by H2O2 in rabbit ventricular cells due to the impaired
fast inactivation (Xie et al. 2009), and INa was shown to increase
RSV (Heijman et al. 2013; Szentandrássy et al. 2015). In addition,
elevation of [Na+]i is known to be followed by intracellular Ca2+
accumulation. Indeed, accumulation of cytosolic Ca2+ was ob-
served with H2O2 in rabbit ventricular cells (Anzai et al. 2000;
Goldhaber and Liu 1994; Xie et al. 2009; Zissimopoulos and Lai
2006) and elevated [Ca2+]i has been reported to increase the beat-
to-beat variability of APD (Johnson et al. 2013; Kistamás et al.
2015a; Szentandrássy et al. 2015). However, in the absence of rele-
vant voltage clamp data, the role of INa remains to be supported
experimentally.
Acidosis, the third consequence of an ischemia–reperfusion in-
jury, increases beat-to-beat variability of APD in multicellular
preparations due to the H+-induced closure of the gap junctions
and, therefore, it is proarrhythmic (White et al. 1990). In contrast,
RSV was not inﬂuenced by ±1 pH unit change in isolated canine
ventricular myocytes (Magyar et al. 2016), suggesting that RSV is
increased during ischemia–reperfusion injury by the Ca2+ over-
load and the redox shift, but not by acidosis.
RSV was also increased at high driving rates in canine ventric-
ular cells (Johnson et al. 2010) even if the records with action
potential alternans were excluded from the analysis (Szentandrássy
et al. 2015). Although the underlying mechanism was not studied
directly, it is reasonable to assume that the Ca2+ overload, caused by
the high stimulation frequency, might be responsible for this effect.
Changes in temperature also have inﬂuence on RSV, which was
increased when the superfusate was warmed from 37 to 38–41 °C
in canine cardiomyocytes (Magyar et al. 2016). Thismay contribute
to the increased incidence of cardiac arrhythmias under condi-
tions of fever in addition to many other factors (Amin et al. 2008,
2010; Chockalingam et al. 2011).
In silico analysis
Because SV is believed to be a consequence of stochastic gating
of ion channels, the relative contribution of stochastic ﬂuctuation
of the individual channels/currents were analyzed in silico. De-
pending on the animal model used for the analysis, the contribu-
tion of 3 currents was dominant. In a guinea-pig-based model, the
stochastic ﬂuctuation of IKs and late INa were the major sources of
APD variability (Lemay et al. 2011; Pueyo et al. 2011), while in a
canine/human model, late INa and IKr were the major sources of
APD variability (Heijman et al. 2013). Notably, the relative contri-
bution of these currents to ventricular repolarization is different
in these species. In dogs and humans, IKr is the main repolarizing
ion current, while in guinea pigs, IKs is the main repolarizing ion
current (Varró et al. 2000; Virág et al. 2001). Interestingly, ﬂuctu-
ations of ICa, the current mediating inward current during almost
the entire plateau, had much less impact (Heijman et al. 2013;
Lemay et al. 2011). These simulations can detect correlation be-
tween APD variability and the ﬂuctuation of channel gating of a
particular ion channel type, while keeping the total conductance
for the given ion (number of channels × single channel conduc-
tance) constant. Under real-life conditions, such as when an ion
channel blocker is applied, speciﬁc membrane conductances are
modiﬁed. This should be taken into consideration when the ex-
perimental results obtained with selective ion channel blockers
(Szentandrássy et al. 2015) are compared with predictions of in
silico models.
Summary
As has been pointed out in this review, several factors were
found to modulate beat-to-beat variability in mammalian cardiac
tissues (Fig. 3). Reduction of gap junction conductance in multi-
cellular preparations and increased APD in single cardiomyocytes
were the most prominent factors increasing SV. Importantly, SV
was an exponential function of APD. To balance this inﬂuence of
APD on SV, the concept of RSV has been introduced (Magyar et al.
2016; Szentandrássy et al. 2015). RSV was increased by elevation of
temperature, heart rate, and cytosolic Ca2+ concentration, and
also by oxidative shifts in the tissue redox potential. Accordingly,
the changes in RSV during ischemia–reperfusion injury or fever
have been discussed. However, themost prominent effects on RSV
were observed due to alterations of the transmembrane ion cur-
rents; more speciﬁcally, RSV was increased when IKr, IKs, and ICa
were suppressed, or INa was increased (Szentandrássy et al. 2015).
Implications for the future
Factors modulating beat-to-beat variability of APD are known to
be present under conditions ofmany cardiac disorders potentially
associated with severe cardiac arrhythmias. This group contains
almost all types of the inherited long QT syndrome, caused by
mutations of ion channels mediating IKr, IKs, and INa (Goldenberg
and Moss 2008; Schwartz et al. 2012). Acquired forms of the long
QT syndrome are typically related to drugs or nutrients that de-
crease the intensity of IKr, including anti-allergic compounds, anti-
biotics, antipsychotics, nonsteroid anti-inﬂammatory drugs, or
simple grapefruit juice (Gupta et al. 2007; Zitron et al. 2005). Com-
mon in the action of these agents is that they reduce the repolar-
ization reserve of cardiac cells (Biliczki et al. 2002). Similarly,
diseases like idiopathic cardiomyopathy, cardiac hypertrophy, or
heart failure, in addition to the characteristically altered cellular
Ca2+ handling, may cause remodeling of cardiac ion channels. Ion
channel remodeling involves the reduction of K+ current densities
in many cases, compromising the repolarization reserve (Volders
et al. 1999). Because SVwas found to be one of the best arrhythmia
predictors, it is logical to incorporate automated, ECG-aided SV
analysis into the long-term follow-up strategy of these patients.
The other ﬁeld where examination of SV or RSV would be highly
beneﬁcial is the screening of athletes. Although the incidence of
Fig. 3. Factors decreasing (left panel) or increasing (right panel) the
short-term variability (SV)of action potential duration (APD). High
electrical coupling reﬂects the physiological status of electrical cell-to-cell
coupling in multicellular cardiac tissue. Low electrical coupling reﬂects
situations resulting in compromised electrical cell-to-cell coupling.
Arrows (↓ and ↑) indicate deviations from the physiologically normal
range of values of the particular parameter in the negative or positive
direction, respectively. IKr, IKs, and ICa are grouped together to reﬂect
their interdependent role in the feedback regulation of APD. [Ca2+]i
stands for intracellular calcium concentration. Reductive and oxidative
milieu indicate shifts of redox potential of the cell interior in the
reductive or oxidative direction, respectively.
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sudden cardiac death (typically due to ventricular ﬁbrillation) is rel-
atively low in the gross population (only 1/50 000 to 1/100 000), its
prevalence in top athletes is close to 4-fold (Maron 2007; Pigozzi and
Rizzo 2008). These individuals usually display adaptive hypertrophy
(Atchley and Douglas 2007; Di Paolo and Pelliccia 2007; Scharhag
et al. 2002) and may apply drugs or medications known to diminish
the repolarization reserve (see the list above). Combination of a con-
genital or acquired long QT syndrome with the adaptive cardiomy-
opathymaybepotentially fatal for athletes (Basavarajaiahet al. 2007;
Ng and Maginot 2007; Kapetanopoulos et al. 2006). Therefore, the
most risky cases could be easily screened out using determination
of SV under normal, or probablymore effectively, under “provoked”
conditions, which could be followed by the more expensive genetic
tests in the positive cases (Varró and Baczkó 2010).
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